Long COVID after breakthrough SARS-CoV-2 infection
Covid19-Sources
Anti-nucleocapsid antibodies enhance the production of IL-6 induced by SARS-CoV-2 N protein
Association between Self-reported Masking Behavior and SARS-CoV-2 Infection Wanes from Pre-Delta to Omicron-Predominant Periods — North Carolina COVID-19 Community Research Partnership
Palaeoserology – teeth put into ancient plagues and pandemics
Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2
Jüngste Stiko-Empfehlung: Ein bisschen Impfen?
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Cardiac Complications More Common After COVID-19 Than Vaccination
Corona OpenData bei Rainer Gerhards - rainer-gerhards.de
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Variant-specific symptoms of COVID-19 among 1,542,510 people in England
Transmission of SARS-CoV-2 from humans to animals and potential host adaptation
The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries
The Sato Lab (Kei Sato) on Twitter
Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol
Eric Topol on Twitter
Rapid Relapse of Symptomatic Omicron SARS-CoV-2 Infection Following Early Suppression with Nirmatrelvir/Ritonavir
SARS-CoV-2 Transmission and Shedding According to Vaccination Status
COVID vaccines may impair long-term immunity to the virus
CDC to investigate whether adenovirus is 'incidental' in children with mysterious hepatitis
SARS-CoV-2 ORF1abA1061S potentiate autoreactive T cell responses via epitope mimicry: an explanation to hepatitis of unknown cause
Safety of the BNT162b2 mRNA COVID-19 Vaccine in Children below 5 Years (CoVacU5) – an Investigator-Initiated Retrospective Cohort Study
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Post–COVID-19 Conditions Among Adult...
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings | Annals of Internal Medicine
Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection | NEJM
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
Eric Topol on Twitter
Neuroinvasion by Human Respiratory Coronaviruses